{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:41:02Z","timestamp":1782362462080,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T00:00:00Z","timestamp":1165017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2007,2,20]]},"DOI":"10.1007\/s11255-006-0073-7","type":"journal-article","created":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T09:34:38Z","timestamp":1165052078000},"page":"559-564","source":"Crossref","is-referenced-by-count":10,"title":["Age-specific reference ranges for prostate specific antigen-total and free in patients with prostatitis symptoms and patients at risk"],"prefix":"10.1007","volume":"38","author":[{"given":"M. N. G.","family":"Battikhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,2]]},"reference":[{"issue":"4","key":"73_CR1","first-page":"385","volume":"121","author":"RG Nixon","year":"1997","unstructured":"Nixon RG, Lilly JD, Liedtke RJ, Batjer JD (1997) Variation of free and total prostate-specific antigen levels: the effect on the percent free\/total-specific antigen. Arch Pathol Lab Med Northfield 121(4):385\u2013387","journal-title":"Arch Pathol Lab Med Northfield"},{"key":"73_CR2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona WJ, Smith TL, Ratliff et al (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156\u20131161","journal-title":"N Engl J Med"},{"key":"73_CR3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","volume":"145","author":"JE Oestrling","year":"1991","unstructured":"Oestrling JE (1991) Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145:907\u2013923","journal-title":"J Urol"},{"key":"73_CR4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1995.03530180039027","volume":"274","author":"SJ Jacobsen","year":"1995","unstructured":"Jacobsen SJ, Katusic SK, Bergstraih et al (1995) Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 274:1445\u20131449","journal-title":"JAMA"},{"key":"73_CR5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","volume":"270","author":"JE Oestrling","year":"1993","unstructured":"Oestrling JE, Jacobsen SJ (1993) Serum prostate-specific antigen in community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270:860\u2013864","journal-title":"JAMA"},{"key":"73_CR6","first-page":"671","volume":"20","author":"JE Oesterling","year":"1993","unstructured":"Oesterling JE, Cooner WH (1993) Influence of patient age on serum PSA concentration. An important clinical observation. Urol Clin North Am 20:671\u2013680","journal-title":"Urol Clin North Am"},{"key":"73_CR7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-5347(17)38972-3","volume":"142","author":"MA Hudson","year":"1989","unstructured":"Hudson MA, Bahnson RR (1989) Clinical use prostate specific antigen in patients with prostate cancer. J.Urol 142:1011\u20131117","journal-title":"J.Urol"},{"issue":"2","key":"73_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1007132926635","volume":"31","author":"S Resim","year":"1999","unstructured":"Resim S, Cez M, Gurbuz ZG, Fazlioglu A, Caskurlu T, Uras AR, Stevin G (1999) Serum PSA and age-specific reference ranges in patients with prostatism symptoms. Int Urol Nephrol 31(2):221\u2013228","journal-title":"Int Urol Nephrol"},{"key":"73_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"TA Stamy","year":"1987","unstructured":"Stamy TA, Yang N, Hay AR, Mcneal JF, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarsenoma of the prostate. N Engl J Med 317:909\u2013916","journal-title":"N Engl J Med"},{"key":"73_CR10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.7326\/0003-4819-119-9-199311010-00015","volume":"119","author":"PC Walsh","year":"1993","unstructured":"Walsh PC (1993) Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters. Ann intern Med 119:984\u2013949","journal-title":"Ann intern Med"},{"issue":"5","key":"73_CR11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199608013350502","volume":"335","author":"TO Morgan","year":"1996","unstructured":"Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, MclacLeod DG, Moul JW (1996) Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med 335(5):304\u2013310","journal-title":"N Engl J Med"},{"key":"73_CR12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1464-410X.1988.tb04431.x","volume":"62","author":"TG Armitage","year":"1988","unstructured":"Armitage TG, Cooper EH (1988) The value of the measurement of serum prostate-specific antigen in patients with benign prostatic hypereplasis and untreated prostate cancer. Br J Urol 62:584\u2013589","journal-title":"Br J Urol"},{"key":"73_CR13","first-page":"421A","volume":"149","author":"PD Sershon","year":"1993","unstructured":"Sershon PD, Barry MJ, Oestrling JE (1993) Serum PSA values in men with histologically confirmed BPH versus patients with organ-confined prostate cancer (abstract.). J\u2423Urol 149:421A","journal-title":"J Urol"},{"key":"73_CR14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","volume":"151","author":"WJ Catalona","year":"1994","unstructured":"Catalona WJ, Richie JP, Ahmann FR et al (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 151:1283\u20131290","journal-title":"J Urol"},{"key":"73_CR15","doi-asserted-by":"crossref","first-page":"412A","DOI":"10.1016\/S0022-5347(17)36106-2","volume":"149","author":"JE Oestrerling","year":"1993","unstructured":"Oestrerling JE, Chute CG (1993) Longitudinal changes in serum PSA (PSA velocity) in a community-based cohort of men (Abstract). J Urol 149:412A","journal-title":"J Urol"},{"key":"73_CR16","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.1992.03480160073037","volume":"267","author":"HB Carter","year":"1992","unstructured":"Carter HB, Pearson JD (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215\u20132220","journal-title":"JAMA"},{"key":"73_CR17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-5347(17)41037-8","volume":"141","author":"OH Lange","year":"1989","unstructured":"Lange OH, Ercole CJ (1989) The value of serum prostate-specific antigen determinations before and after radical prostatectomy. J Urol 141:873","journal-title":"J Urol"},{"key":"73_CR18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","volume":"270","author":"JE Osterling","year":"1993","unstructured":"Osterling JE, Jacobsen SJ, Chute CG et al (1993) Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270:860\u2013864","journal-title":"JAMA"},{"key":"73_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0090-4295(99)80158-7","volume":"46","author":"JR Anderson","year":"1995","unstructured":"Anderson JR, Strickland D, Corbin D, Byrnes JA, Zweiback E (1995) Age-specific reference ranges for serum prostate-specific antigen. Urology 46:54\u201357","journal-title":"Urology"},{"key":"73_CR20","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1097-0142(19950401)75:7+<1874::AID-CNCR2820751618>3.0.CO;2-I","volume":"75","author":"EP DeAntoni","year":"1995","unstructured":"DeAntoni EP, Crawford ED (1995) Prostate cancer awarness week: education, service, and research in a community setting. Cancer 75:1874\u20131879","journal-title":"Cancer"},{"key":"73_CR21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0022-5347(17)35910-4","volume":"150","author":"BL Dalkin","year":"1993","unstructured":"Dalkin BL, Ahmann FR, Kopp JB (1993) Prostate specific antigen levels in men older than 50\u00a0years without clinical evidence of prostatic carcinoma. J Urol 150:1837\u20131839","journal-title":"J Urol"},{"key":"73_CR22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0090-4295(99)80194-0","volume":"46","author":"RES el-Galley","year":"1995","unstructured":"el-Galley RES, Petro JA, Sanders WH et al (1995) Normal range prostatic-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. Urology 46:200\u2013204","journal-title":"Urology"},{"issue":"2","key":"73_CR23","first-page":"29","volume":"13","author":"ChM Niederau","year":"1998","unstructured":"Niederau ChM, Beyrau R, Gurr E, Neumeier D, Peisker K, Raith H, Wood P, Domke I (1998) External evaluation of tumor markers on elesys 1010 immunoanalyzer. Tumor Marker Oncol 13(2):29\u201330","journal-title":"Tumor Marker Oncol"},{"key":"73_CR24","volume-title":"Principle and procedures of statistics","author":"RG Steel","year":"1980","unstructured":"Steel RG, Torrie JH (1980) Principle and procedures of statistics. McGraw-Hill Book Co, New York"},{"issue":"3 Pt 2","key":"73_CR25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","volume":"147","author":"MC Benson","year":"1992","unstructured":"Benson MC, Whang IS, Pantuck A, Ring K et al (1992) Prostate-specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147(3 Pt 2):815\u2013816","journal-title":"J Urol"},{"key":"73_CR26","first-page":"414A","volume":"149","author":"E Seamean","year":"1993","unstructured":"Seamean E, Katz A (1993) An algorithm for prostate cancer detection based upon PSA TRUS, DRE, PSA density, and PSA velocity (Abstract). J Urol 149:414A","journal-title":"J Urol"},{"key":"73_CR27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-5347(01)63572-9","volume":"159","author":"M Riehman","year":"1998","unstructured":"Riehman M, Rhodes PR (1998) Analysis of variation in prostate-specific antigen values. Urol 159:1243\u20131246","journal-title":"Urol"},{"key":"73_CR28","first-page":"413A","volume":"149","author":"L Dalkin","year":"1993","unstructured":"Dalkin L, Ahman F (1993) Derivation of normal prostate specific antigen (PSA) level by age (Abstract). J Urol 149:413A","journal-title":"J Urol"},{"key":"73_CR29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.pcan.4500656","volume":"6","author":"MNG Battikhi","year":"2003","unstructured":"Battikhi MNG (2003) Age-specific reference ranges for prostate-specific (PSA) antigen in Jordanian patients. Prostate Cancer and Prostatic Dis 6:256\u2013260","journal-title":"Prostate Cancer and Prostatic Dis"},{"key":"73_CR30","first-page":"55A","volume":"149","author":"ED Crawford","year":"1993","unstructured":"Crawford ED (1993) Report on the 1992 Prostate Cancer Awareness Week (Abstract). J Urol 149:55A","journal-title":"J Urol"},{"key":"73_CR31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0090-4295(98)00448-8","volume":"52","author":"C Martin","year":"1998","unstructured":"Martin C, Weinrich A, Jacobsen ST et al (1998) Reference ranges for serum prostate-specific antigen in black and white men without cancer. Urology 52:967\u2013973","journal-title":"Urology"},{"key":"73_CR32","first-page":"1029","volume":"9","author":"R Sawyer","year":"1996","unstructured":"Sawyer R, Berman JJ, Borkowski A, William MG (1996) Elevated prostate-specific antigen levels in black men and white men. Mod Pathol 9:1029\u20131032","journal-title":"Mod Pathol"},{"issue":"3","key":"73_CR33","first-page":"284","volume":"37","author":"RJ Hicks","year":"1993","unstructured":"Hicks RJ (1993) Elevated prostate-specific antigen: a case report and analysis. J Fam Pract 37(3):284\u2013288","journal-title":"J Fam Pract"},{"key":"73_CR34","unstructured":"Battikhi MN, Hussein I Serum prostate-specific antigen (PSA) in men without clinical evidence of prostate cancer. J Tumor Oncol Marker (In Press)"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-0073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-006-0073-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-0073-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:55:15Z","timestamp":1559390115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-006-0073-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,2]]},"references-count":34,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2007,2,20]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s11255-006-0073-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,2]]}}}